Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.
Also called NCT02545231
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,000 participants
- Registry
-
NCT02545231
-
- Other papers using this trial's data
- Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02545231. Randomized; double masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2018-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
- Acronym
- ELEVATE
- Condition
- Atherosclerosis
- Condition
- Neointima
- Condition
- Angina
- Intervention (Drug)
- Pitavastatin 1mg
- Intervention (Drug)
- Pitavastatin 4mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Korea University Anam Hospital
Record details
- Record id
cardio:ct-nct02545231- Content hash
81e462ec9f270e58e89a5df6625a82a1f3ab60a80ddb4a683f7cb42c64bf6dc1